Diagnostics
First public trial of DnaNudge’s technology has today been launched to study effects of DNA-based food choices for pre-diabetic individuals
Acquisition of Illumina NovaSeq instrument increases throughput & quality and reduces cost
Owlstone Medical today announces the appointment of Dr. Richard A Yost to its Scientific Advisory Board.
Medopad, a U.K.-based medical firm, and China-based Tencent Holdings, have teamed up on a project that will attempt to harness artificial intelligence in the diagnosis of Parkinson’s disease.
Guardant Health went on the Nasdaq yesterday under the symbol GH. Shares climbed almost 70 percent on the first day of trading, selling 12.5 million shares at $19 per share in the initial public offering (IPO).
Epigenomics AG today announced that the U.S. Congress urges the Centers of Medicare & Medicaid Services (CMS) to consider coverage of colorectal cancer screening blood tests as part of the approved 2019 Health and Human Services (HHS) Appropriations Bill.
Karius today announced the winners for its 2018 Clinical Investigator Awards for Applied Infectious Disease Genomics.
Investment will fund the global commercialization of Owlstone Medical’s Breath Biopsy® platform for early disease detection and precision medicine
A new cardiovascular imaging tool could prevent the possibility of people experiencing a second or third heart attack.
Ilan Danieli, chief executive officer and co-founder of Precipio, a company with a liquid biopsy technology, took time to talk to BioSpace about the company and the economics of liquid biopsies.
PRESS RELEASES